Tower Research Capital (TRC)’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1K | Buy |
14,657
+3,499
| +31% | +$3.85K | ﹤0.01% | 3795 |
|
|
2025
Q1 | $10.9K | Buy |
11,158
+3,720
| +50% | +$3.65K | ﹤0.01% | 3590 |
|
|
2024
Q4 | $11.6K | Buy |
7,438
+3,283
| +79% | +$5.12K | ﹤0.01% | 3693 |
|
|
2024
Q3 | $15.2K | Buy |
+4,155
| New | +$15.2K | ﹤0.01% | 3418 |
|
|
2024
Q2 | – | Sell |
-9,706
| Closed | -$41.3K | – | 5946 |
|
|
2024
Q1 | $41.3K | Buy |
9,706
+4,067
| +72% | +$17.3K | ﹤0.01% | 2411 |
|
|
2023
Q4 | $10.2K | Buy |
5,639
+3,656
| +184% | +$6.58K | ﹤0.01% | 4285 |
|
|
2023
Q3 | $3.95K | Buy |
+1,983
| New | +$3.95K | ﹤0.01% | 4939 |
|
|
2023
Q2 | – | Sell |
-10,866
| Closed | -$43K | – | 6273 |
|
|
2023
Q1 | $43K | Buy |
10,866
+4,688
| +76% | +$18.6K | ﹤0.01% | 2640 |
|
|
2022
Q4 | $8K | Sell |
6,178
-9,558
| -61% | -$12.4K | ﹤0.01% | 4442 |
|
|
2022
Q3 | $31K | Buy |
15,736
+12,676
| +414% | +$25K | ﹤0.01% | 3583 |
|
|
2022
Q2 | $7K | Buy |
3,060
+437
| +17% | +$1K | ﹤0.01% | 4820 |
|
|
2022
Q1 | $11K | Buy |
2,623
+1,960
| +296% | +$8.22K | ﹤0.01% | 4202 |
|
|
2021
Q4 | $7K | Buy |
+663
| New | +$7K | ﹤0.01% | 4932 |
|